REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.87M | 6.08M | -51.19M | -59.60M | -52.99M |
| Total Depreciation and Amortization | 3.91M | 3.96M | 4.02M | 3.96M | 4.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.09M | 7.18M | 3.88M | 9.02M | 7.48M |
| Change in Net Operating Assets | 7.54M | 16.41M | 11.66M | 6.07M | -4.04M |
| Cash from Operations | -49.34M | 33.63M | -31.62M | -40.55M | -45.50M |
| Capital Expenditure | -391.00K | -1.02M | -1.08M | -326.00K | -474.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -140.05M | 45.77M | 41.35M | 50.58M | 206.00K |
| Cash from Investing | -140.44M | 44.74M | 40.27M | 50.26M | -268.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 78.00K | 457.00K | 38.00K | 644.00K | -- |
| Repurchase of Common Stock | 0.00 | -510.00K | 0.00 | 0.00 | -57.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 139.15M | -5.74M | -7.78M | -11.50M | -9.39M |
| Cash from Financing | 139.23M | -5.79M | -7.74M | -10.86M | -9.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.55M | 72.58M | 909.00K | -1.15M | -55.21M |